Christopher L. D. McMillan

Author

Also Known As

Christopher L D McMillan, Christopher L. D. McMillan, Christopher L.D. McMillan, Christopher LD McMillan, Christopher McMillan

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Queensland Vaxxas (Australia)Translational Research Institute QIMR Berghofer Medical Research Institute Griffith University

About

Christopher L. D. McMillan is an author at The University of Queensland specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	420
2	Engineering	1	1	19
3	Allergy	1	1	47
4	Biomedical Engineering	1	1	19
5	Epidemiology	1	1	67

Christopher L. D. McMillan

Publications

963

Citations

H-Index

Page 1

	Year	Citations
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses Alberto A. Amarilla, Julian D. J. Sng, Rhys Parry, Nature Communications	2021	167
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, Molecular Psychiatry	2022	164
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19 Adi Idris, Alicia Davis, Aroon Supramaniam, Molecular Therapy NanomedicineAntiviral TherapyVirologyAntiviral DrugMedicine	2021	159
An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2 Alberto A. Amarilla, Naphak Modhiran, Yin Xiang Setoh, Frontiers in Microbiology VaccinationPlaque AssayDiagnostic VirologyViral DiagnosticsEmerging Infectious Diseases	2021	67
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2 Daniel Watterson, Danushka K. Wijesundara, Naphak Modhiran, Clinical & Translational Immunology	2021	61
Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris, Science Advances ImmunologyImmunodominanceImmunotherapeuticsCovid-19Complete Protection	2021	47
A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice Jovin J. Y. Choo, Laura J. Vet, Christopher L. D. McMillan, npj Vaccines VaccinationVaccine DevelopmentDengue VirusesVaccine TargetImmunology	2021	33
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 Cecy Xi, Arianna Di Fazio, Naveed A. Nadvi, Molecules	2020	31
A platform technology for generating subunit vaccines against diverse viral pathogens Andrew Young, Ariel Isaacs, Connor A. P. Scott, Frontiers in Immunology Vaccine Platform TechnologiesImmunologyImmunodominanceViral Structural ProteinCovid-19	2022	23
Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants Ariel Isaacs, Alberto A. Amarilla, Julio Aguado, Frontiers in Immunology Viral DiagnosticsImmunologyDiagnosisPathologyMolecular Biology	2022	21

Page 1